FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890157050> ?p ?o ?g. }

• W2890157050 endingPage "1280" @default.
• W2890157050 startingPage "1272" @default.
• W2890157050 abstract "Dopamine D2 receptor antagonists used to treat Tourette syndrome may have inadequate responses or intolerable side effects. We present results of a 4-week randomized, double-blind, placebo-controlled crossover study evaluating the safety, tolerability, and efficacy of the D1 receptor antagonist ecopipam in children and adolescents with Tourette syndrome.Forty youth aged 7 to 17 years with Tourette syndrome and a Yale Global Tic Severity Scale - total tic score of ≥20 were enrolled and randomized to either ecopipam (50 mg/day for weight of <34 kg, 100 mg/day for weight of >34 kg) or placebo for 30 days, followed by a 2-week washout and then crossed to the alternative treatment for 30 days. Stimulants and tic-suppressing medications were excluded. The primary outcome measure was the total tic score. Secondary outcomes included obsessive compulsive and attention deficit/hyperactivity disorder scales.Relative to changes in placebo, reduction in total tic score was greater for ecopipam at 16 days (mean difference, -3.7; 95% CI, -6.5 to -0.9; P = 0.011) and 30 days (mean difference, -3.2; 95% CI, -6.1 to -0.3; P = 0.033). There were no weight gain, drug-induced dyskinesias, or changes in laboratory tests, electrocardiograms, vital signs, or comorbid symptoms. Dropout rate was 5% (2 of 40). Adverse events reported for both treatments were rated predominantly mild to moderate, with only 5 rated severe (2 for ecopipam and 3 for placebo).Ecopipam reduced tics and was well tolerated. This placebo-controlled study of ecopipam supports further clinical trials in children and adolescents with Tourette syndrome. © 2018 International Parkinson and Movement Disorder Society." @default.
• W2890157050 created "2018-09-27" @default.
• W2890157050 creator A5005424070 @default.
• W2890157050 creator A5012235859 @default.
• W2890157050 creator A5031288381 @default.
• W2890157050 creator A5042095130 @default.
• W2890157050 creator A5044457835 @default.
• W2890157050 creator A5046178026 @default.
• W2890157050 creator A5055252759 @default.
• W2890157050 creator A5064962710 @default.
• W2890157050 creator A5068655451 @default.
• W2890157050 creator A5072919987 @default.
• W2890157050 creator A5089087983 @default.
• W2890157050 date "2018-08-01" @default.
• W2890157050 modified "2023-10-18" @default.
• W2890157050 title "Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study" @default.
• W2890157050 cites W1590304146 @default.
• W2890157050 cites W1970956587 @default.
• W2890157050 cites W1971999279 @default.
• W2890157050 cites W1983555259 @default.
• W2890157050 cites W1997791967 @default.
• W2890157050 cites W2004303197 @default.
• W2890157050 cites W2006001020 @default.
• W2890157050 cites W2013333057 @default.
• W2890157050 cites W2016145400 @default.
• W2890157050 cites W2019101336 @default.
• W2890157050 cites W2020925019 @default.
• W2890157050 cites W2027467481 @default.
• W2890157050 cites W2036284238 @default.
• W2890157050 cites W2047755869 @default.
• W2890157050 cites W2056662741 @default.
• W2890157050 cites W2081841619 @default.
• W2890157050 cites W2091745455 @default.
• W2890157050 cites W2095980768 @default.
• W2890157050 cites W2099652807 @default.
• W2890157050 cites W2114487561 @default.
• W2890157050 cites W2117757868 @default.
• W2890157050 cites W2119545761 @default.
• W2890157050 cites W2119753690 @default.
• W2890157050 cites W2148083007 @default.
• W2890157050 cites W2160753798 @default.
• W2890157050 cites W2182541551 @default.
• W2890157050 cites W2196465527 @default.
• W2890157050 cites W2294027246 @default.
• W2890157050 cites W2583436748 @default.
• W2890157050 cites W2588198995 @default.
• W2890157050 cites W2588681049 @default.
• W2890157050 cites W2610487679 @default.
• W2890157050 cites W2726321932 @default.
• W2890157050 cites W2738387807 @default.
• W2890157050 cites W4232101242 @default.
• W2890157050 cites W4234178221 @default.
• W2890157050 cites W4234723356 @default.
• W2890157050 doi "https://doi.org/10.1002/mds.27457" @default.
• W2890157050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30192018" @default.
• W2890157050 hasPublicationYear "2018" @default.
• W2890157050 type Work @default.
• W2890157050 sameAs 2890157050 @default.
• W2890157050 citedByCount "52" @default.
• W2890157050 countsByYear W28901570502018 @default.
• W2890157050 countsByYear W28901570502019 @default.
• W2890157050 countsByYear W28901570502020 @default.
• W2890157050 countsByYear W28901570502021 @default.
• W2890157050 countsByYear W28901570502022 @default.
• W2890157050 countsByYear W28901570502023 @default.
• W2890157050 crossrefType "journal-article" @default.
• W2890157050 hasAuthorship W2890157050A5005424070 @default.
• W2890157050 hasAuthorship W2890157050A5012235859 @default.
• W2890157050 hasAuthorship W2890157050A5031288381 @default.
• W2890157050 hasAuthorship W2890157050A5042095130 @default.
• W2890157050 hasAuthorship W2890157050A5044457835 @default.
• W2890157050 hasAuthorship W2890157050A5046178026 @default.
• W2890157050 hasAuthorship W2890157050A5055252759 @default.
• W2890157050 hasAuthorship W2890157050A5064962710 @default.
• W2890157050 hasAuthorship W2890157050A5068655451 @default.
• W2890157050 hasAuthorship W2890157050A5072919987 @default.
• W2890157050 hasAuthorship W2890157050A5089087983 @default.
• W2890157050 hasConcept C118552586 @default.
• W2890157050 hasConcept C126322002 @default.
• W2890157050 hasConcept C142724271 @default.
• W2890157050 hasConcept C15744967 @default.
• W2890157050 hasConcept C168563851 @default.
• W2890157050 hasConcept C197934379 @default.
• W2890157050 hasConcept C204787440 @default.
• W2890157050 hasConcept C27081682 @default.
• W2890157050 hasConcept C2777026814 @default.
• W2890157050 hasConcept C2777200579 @default.
• W2890157050 hasConcept C2778375690 @default.
• W2890157050 hasConcept C42219234 @default.
• W2890157050 hasConcept C71924100 @default.
• W2890157050 hasConcept C87813604 @default.
• W2890157050 hasConceptScore W2890157050C118552586 @default.
• W2890157050 hasConceptScore W2890157050C126322002 @default.
• W2890157050 hasConceptScore W2890157050C142724271 @default.
• W2890157050 hasConceptScore W2890157050C15744967 @default.
• W2890157050 hasConceptScore W2890157050C168563851 @default.
• W2890157050 hasConceptScore W2890157050C197934379 @default.
• W2890157050 hasConceptScore W2890157050C204787440 @default.

• next